Clinical significance of RCAS1 as a biomarker of ovarian cancer

Oncology Reports

Volumn 17, Issue 3, 2007, Pages 623-628

  Sonoda, Kenzo ^a   Miyamoto, Shingo ^b   Yotsumoto, Fusanori ^b   Yagi, Hiroshi ^a   Nakashima, Manabu ^b   Watanabe, Takeshi ^c   Nakano, Hitoo ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c RIKEN Center for Integrative Medical Sciences   (Japan)

Author keywords

Apoptosis; Biologic marker; Ectodomain shedding; ELISA; Ovarian cancer

Indexed keywords

EBAG9 PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADOLESCENT; AGED; ARTICLE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTORY; HUMAN; OVARY TUMOR; PATHOLOGY; PROGNOSIS;

ADOLESCENT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTORY, 16TH CENTURY; HISTORY, 17TH CENTURY; HUMANS; OVARIAN NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 34247893864     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.3.623     Document Type: Article

References (34)

1. Landis SH, Murray T, Bolden S and Wingo PA: Cancer statistics. CA Cancer J Clin 49: 8-31, 1999.
2. Society American Cancer: Cancer Facts and Figures - 2005, American Cancer Society, Inc., 2005.
3. Meyer T and Rustin GJ: Role of tumour markers in monitoring epithelial ovarian cancer. Br J Cancer 82: 1535-1538, 2000. (Pubitemid 30204358)
4. Jacobs IJ and Menon U: Progress and challenges in screening for early detection of ovarian cancer. Mol Cell Proteom 3: 355-366, 2004. (Pubitemid 38702089)
5. Rapkiewicz AV, Espina V, Petricoin EF III and Liotta LA: Biomarkers of ovarian tumours. Eur J Cancer 40: 2604-2612, 2004. (Pubitemid 39487082)
6. Chatterjee M, Mohapatra S, Ionan A, Bawa G, Ali-Fehmi R, Wang X, Nowak J, Ye B, Nahhas FA, Lu K, Witkin SS, Fishman D, Munkarah A, Morris R, Levin NK, Shirley NN, Tromp G, Abrams J, Draghici S and Tainsky MA: Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays. Cancer Res 66: 1181-1190, 2006. (Pubitemid 43165989)
7. Nakashima M, Sonoda K and Watanabe T: Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat Med 5: 938-942, 1999. (Pubitemid 29372422)
8. Sonoda K, Miyamoto S, Hirakawa T, Yagi H, Yotsumoto F, Nakashima M, Watanabe T and Nakano H: Association between RCAS1 expression and microenvironmental immune cell death in uterine cervical cancer. Gynecol Oncol 97: 772-779, 2005. (Pubitemid 40824645)
9. Sonoda K, Nakashima M, Kaku T, Kamura T, Nakano H and Watanabe T: A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas. Cancer 77: 1501-1509, 1996. (Pubitemid 26105386)
10. Razvi K, Sonoda K, Lee YS, Tham KF, Lim FK and Yong EL: A preliminary study of the immunohistochemical detection of a novel tumour marker, 22-1-1 antigen, in gynaecological cancer specimens. Ann Acad Med Singapore 28: 392-394, 1999.
11. Sonoda K, Miyamoto S, Hirakawa T, Yagi H, Yotsumoto F, Nakashima M, Watanabe T and Nakano H: Invasive potency related to RCAS1 expression in uterine cervical cancer. Gynecol Oncol 99: 189-198, 2005. (Pubitemid 41354601)
12. Sonoda K, Kaku T, Kamura T, Nakashima M, Watanabe T and Nakano H: Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias. Clin Cancer Res 4: 1517-1520, 1998. (Pubitemid 28265237)
13. Sonoda K, Kaku T, Hirakawa T, Kobayashi H, Amada S, Sakai K, Nakashima M, Watanabe T and Nakano H: The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic and malignant endometrium. Gynecol Oncol 79: 424-429, 2000.
14. Kaku T, Sonoda K, Kamura T, Hirakawa T, Sakai K, Amada S, Ogawa S, Kobayashi H, Nakashima M, Watanabe T and Nakano H: The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix. Clin Cancer Res 5: 1449-1453, 1999. (Pubitemid 29282951)
15. Sonoda K, Miyamoto S, Hirakawa T, Kaku T, Nakashima M, Watanabe T, Akazawa K, Fujita T and Nakano H: Association between RCAS1 expression and clinical outcome in uterine endometrial cancer. Br J Cancer 89: 546-551, 2003. (Pubitemid 37026441)
16. Akahira JI, Aoki M, Suzuki T, Moriya T, Niikura H, Ito K, Inoue S, Okamura K, Sasano H and Yaegashi N: Expression of EBAG9/RCAS1 is associated with advanced disease in human epithelial ovarian cancer. Br J Cancer 90: 2197-2202, 2004. (Pubitemid 38869730)
17. Sonoda K, Miyamoto S, Hirakawa T, Yagi H, Yotsumoto F, Nakashima M, Watanabe T and Nakano H: Clinical significance of RCAS1 as a biomarker of uterine cancer. Gynecol Oncol (In press).
18. Menon U, Taalat A, Jeyerajah AR, Rosenthal AN, MacDonald ND, Skates SJ, Sibley K, Oram DH and Jacobs IJ: Ultrasound assessment of ovarian cancer risk in post-menopausal women with CA125 elevation. Br J Cancer 80: 1644-1647, 1999. (Pubitemid 29308649)
19. Jacobs IJ, Skates SJ, MacDonald N, Menon U, Rosenthal A, Davies R, Woolas AP, Jeyarajah AR, Sibley K, Lowe DG and Oram DH: Screening for ovarian cancer: a pilot randomized control trial. Lancet 353: 1207-1210, 1999. (Pubitemid 29168457)
20. Schwartz PE and Taylor KJ: Is early detection of ovarian cancer possible? Ann Med 27: 519-528, 1995.
21. Wong C, Dai ZM, Lele SB and Natarajan N: Comparison of CA125 after three courses of chemotherapy and results of second-look surgery. Eur J Gynaecol Oncol 21: 70-73, 2000. (Pubitemid 30088093)
22. Kawano Y, Kaku T, Sonoda K, Hirakawa T, Kobayashi H, Ohishi Y and Nakano H: Expression of RCAS1 in female genital organs. Int J Gynecol Pathol 24: 330-334, 2005. (Pubitemid 41368284)
23. Akashi T, Oimomi H, Nishiyama K, Nakashima M, Arita Y, Sumii T, Kimura T, Ito T, Nawata H and Watanabe T: Expression and diagnostic evaluation of the human-associated antigen RCAS1 in pancreatic cancer. Pancreas 26: 49-55, 2003. (Pubitemid 36020266)
24. Yamaguchi K, Enjoji M, Nakashima M, Nakamuta M, Watanabe T and Tanaka M: Novel serum tumor marker, RCAS1, in pancreatic diseases. World J Gastroenterol 11: 5199-5202, 2005. (Pubitemid 41410339)
25. Enjoji M, Nakashima M, Yamaguchi K, Kotoh K and Nakamuta M: Significance of RCAS1 antigen in hepatocellular, cholangiocellular and pancreatic carcinomas. J Gastroenterol Hepatol 20: 1143-1148, 2005. (Pubitemid 41602555)
26. Massague J and Pandiella A: Membrane-anchored growth factors. Annu Rev Biochem 62: 515-541, 1993. (Pubitemid 23237880)
27. Rose-John S and Heinrich PC: Soluble receptors for cytokines and growth factors: generation and biological function. Biochem J 300: 281-290, 1994. (Pubitemid 24167878)
28. Izumi Y, Hirata M, Hasuwa H, Iwamoto R, Umata T, Miyado K, Tamai Y, Kurisaki T, Sehara-Fujisawa A, Ohno S and Mekada E: A metalloprotease- disintegrin, MDC9/meltrin-γ/ADAM9 and PKCδ are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. EMBO J 17: 7260-7272, 1998. (Pubitemid 29002695)
29. Bellone G, Smirne C, Carbone A, Mareschi K, Dughera L, Farina EC, Alabiso O, Valente G, Emanuelli G and Rodeck U: Production and pro-apoptotic activity of soluble CD95 ligand in pancreatic carcinoma. Clin Cancer Res 6: 2448-2455, 2000. (Pubitemid 30399214)
30. Montero JC, Yuste L, Diaz-Rodrigues E, Esparis-Ogando A and Pandiella A: Mitogen-activated protein kinase-dependent and independent routes control shedding of transmembrane growth factors through multiple secretases. Biochem J 363: 211-221, 2002. (Pubitemid 34415757)
31. Hsu CY, Bristow R, Cha MS, Wang BG, Ho CL, Kurman RJ, Wang TL and Shih IM: Characterization of active mitogen-activated protein kinase in ovarian serous carcinomas. Clin Cancer Res 10: 6432-6436, 2004. (Pubitemid 39346537)
32. Steinmetz R, Wagoner HA, Zeng P, Hammond JR, Hannon TS, Meyers JL and Pescovitz OH: Mechanisms regulating the constitutive activation of the extracellular signal-regulated kinase (ERK) signaling pathway in ovarian cancer and the effect of ribonucleic acid interference for ERK1/2 on cancer cell proliferation. Mol Endocrinol 18: 2570-2582, 2004. (Pubitemid 39335989)
33. Kubokawa M, Nakashima M, Yao T, Ito KI, Harada N, Nawata H and Watanabe T: Aberrant intracellular localization of RCAS1 is associated with tumor progression of gastric cancer. Int J Oncol 19: 695-700, 2001.
34. Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, Makrigiannakis A, Gray H, Schlienger K, Liebman MN, Rubin SC and Coukos G: Intratumoral T cells, recurrence and survival in epithelial ovarian cancer. N Engl J Med 348: 203-213, 2003. (Pubitemid 36077915)